Upregulation of PD‐L1 by SARS‐CoV‐2 promotes immune evasion
Journal of Medical Virology · 2023-02 · 95 (2)
DOI: 10.1002/jmv.28478 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 17.01.2023. Verfasst von Hsiang-Chi Huang und 25 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. Hauptthemen laut MEDLINE: COVID-19, Lymphopenia. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS, Academia Sinica, Ministry of Science and Technology.
Abstract (Originalsprache)
Patients with severe COVID‐19 often suffer from lymphopenia, which is linked to T‐cell sequestration, cytokine storm, and mortality. However, it remains largely unknown how severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) induces lymphopenia. Here, we studied the transcriptomic profile and epigenomic alterations involved in cytokine production by SARS‐CoV‐2‐infected cells. We adopted a reverse time‐order gene coexpression network approach to analyze time‐series RNA‐sequencing data, revealing epigenetic modifications at the late stage of viral egress. Furthermore, we identified SARS‐CoV‐2‐activated nuclear factor‐κB (NF‐κB) and interferon regulatory factor 1 (IRF1) pathways contributing to viral infection and COVID‐19 severity through epigenetic analysis of H3K4me3 chromatin immunoprecipitation sequencing. Cross‐referencing our transcriptomic and epigenomic data sets revealed that coupling NF‐κB and IRF1 pathways mediate programmed death ligand‐1 (PD‐L1) immunosuppressive programs. Interestingly, we observed higher PD‐L1 expression in Omicron‐infected cells than SARS‐CoV‐2 infected cells. Blocking PD‐L1 at an early stage of virally‐infected AAV‐hACE2 mice significantly recovered lymphocyte counts and lowered inflammatory cytokine levels. Our findings indicate that targeting the SARS‐CoV‐2‐mediated NF‐κB and IRF1‐PD‐L1 axis may represent an alternative strategy to reduce COVID‐19 severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
- Genomics Research Center, Academia Sinica, Taipei, Taiwan.
- Biomedical Translational Research Center, Academia Sinica, Taipei, Taiwan.
- Department of Neurology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA.
- Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
- Institute for Stem Cell Biology and Regenerative Medicine, Stanford University Medical Center, Stanford, California, USA.
ORCID-Profile: Hsiang-Chi Huang
Förderung
- NIMH NIH HHS
- Academia Sinica
- Ministry of Science and Technology
Zitieren
APA
Huang, H. C., Wang, S. H., Fang, G. C., Chou, W. C., Liao, C. C., Sun, C. P., Jan, J. T., Ma, H. H., Ko, H. Y., Ko, Y. A., Chiang, M. T., Liang, J. J., Kuo, C. T., Lee, T. A., Morales-Scheihing, D., Shen, C. Y., Chen, S. Y., McCullough, L. D., Cui, L., …, & Li, C. W. (2023). Upregulation of PD‐L1 by SARS‐CoV‐2 promotes immune evasion. Journal of Medical Virology, 95(2). https://doi.org/10.1002/jmv.28478
Vancouver
Huang HC, Wang SH, Fang GC, Chou WC, Liao CC, Sun CP, et al. Upregulation of PD‐L1 by SARS‐CoV‐2 promotes immune evasion. Journal of Medical Virology. 2023;95(2). doi:10.1002/jmv.28478
BibTeX
@article{Huang2023,
author = {Huang, Hsiang-Chi and Wang, Shih-Han and Fang, Guo-Chen and Chou, Wen-Cheng and Liao, Chun-Che and Sun, Cheng-Pu and Jan, Jia-Tsrong and Ma, Hsiu-Hua and Ko, Hui-Ying and Ko, Yi-An and Chiang, Ming-Tsai and Liang, Jian-Jong and Kuo, Chun-Tse and Lee, Te-An and Morales-Scheihing, Diego and Shen, Chen-Yang and Chen, Shih-Yu and McCullough, Louise D and Cui, Lu and Wernig, Gerlinde and Tao, Mi-Hua and Lin, Yi-Ling and Chang, Yao-Ming and Wang, Shu-Ping and Lai, Yun-Ju and Li, Chia-Wei},
title = {Upregulation of PD‐L1 by SARS‐CoV‐2 promotes immune evasion},
journal = {Journal of Medical Virology},
year = {2023},
volume = {95},
number = {2},
doi = {10.1002/jmv.28478}
}
EUVIMED